BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1361 related articles for article (PubMed ID: 32989470)

  • 21. Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study.
    Hadji P; Kauka A; Ziller M; Birkholz K; Baier M; Muth M; Bauer M
    Osteoporos Int; 2014 Apr; 25(4):1369-78. PubMed ID: 24504100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total hip arthroplasty versus hemiarthroplasty in the treatment of active elderly patients over 75 years with displaced femoral neck fractures: a retrospective study.
    Luo S; Qin W; Yu L; Luo R; Liang W
    BMC Musculoskelet Disord; 2023 Sep; 24(1):745. PubMed ID: 37730557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Interrupted Time Series Analysis of Direct Medical Expense and Length of Stay in Elderly Patients with Femoral Neck Fractures Who Underwent Total Hip Arthroplasty and Hemiarthroplasty: A Real World Nationwide Database Study.
    Kim SH; Jang SY; Cha Y; Kim BY; Lee HJ; Kim GO
    Clin Orthop Surg; 2024 Apr; 16(2):217-229. PubMed ID: 38562640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZOLEDRONIC ACID VERSUS ALENDRONATE IN THE TREATMENT OF CHILDREN WITH OSTEOGENESIS IMPERFECTA: A 2-YEAR CLINICAL STUDY.
    Lv F; Liu Y; Xu X; Song Y; Li L; Jiang Y; Wang O; Xia W; Xing X
    Endocr Pract; 2018 Feb; 24(2):179-188. PubMed ID: 29466057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion.
    Chen F; Dai Z; Kang Y; Lv G; Keller ET; Jiang Y
    Osteoporos Int; 2016 Apr; 27(4):1469-1476. PubMed ID: 26556733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study.
    Liang BC; Shi ZY; Wang B; Wu P; Kong LC; Yao JL; Li CW; Shi XL
    Orthop Surg; 2017 Feb; 9(1):103-109. PubMed ID: 28276638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women.
    Bai H; Jing D; Guo A; Yin S
    J Int Med Res; 2013 Jun; 41(3):697-704. PubMed ID: 23669294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of osteoporotic intertrochanteric fractures by zoledronic acid injection combined with proximal femoral nail anti-rotation.
    Li Y; Zhao WB; Wang DL; He Q; Li Q; Pei FX; Liu L
    Chin J Traumatol; 2016 Oct; 19(5):259-263. PubMed ID: 27780504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing total hip arthroplasty and hemiarthroplasty for the treatment of displaced femoral neck fracture in the active elderly over 75 years old: a systematic review and meta-analysis of randomized control trials.
    Liu Y; Chen X; Zhang P; Jiang B
    J Orthop Surg Res; 2020 Jun; 15(1):215. PubMed ID: 32527294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemiarthroplasty versus total arthroplasty for displaced femoral neck fractures in the elderly: meta-analysis of randomized clinical trials.
    Migliorini F; Trivellas A; Driessen A; Quack V; El Mansy Y; Schenker H; Tingart M; Eschweiler J
    Arch Orthop Trauma Surg; 2020 Nov; 140(11):1695-1704. PubMed ID: 32170452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemiarthroplasty compared to total hip arthroplasty for the treatment of femoral neck fractures: a systematic review and meta-analysis.
    Li X; Luo J
    J Orthop Surg Res; 2021 Mar; 16(1):172. PubMed ID: 33658055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial.
    Crawford BA; Kam C; Pavlovic J; Byth K; Handelsman DJ; Angus PW; McCaughan GW
    Ann Intern Med; 2006 Feb; 144(4):239-48. PubMed ID: 16490909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.
    Tan W; Sun J; Zhou L; Li Y; Wu X
    J Clin Pharm Ther; 2016 Oct; 41(5):519-23. PubMed ID: 27440710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subgroup variations in bone mineral density response to zoledronic acid after hip fracture.
    Magaziner JS; Orwig DL; Lyles KW; Nordsletten L; Boonen S; Adachi JD; Recknor C; Colón-Emeric CS; Mesenbrink P; Bucci-Rechtweg C; Su G; Johnson R; Pieper CF
    J Bone Miner Res; 2014 Dec; 29(12):2545-51. PubMed ID: 24839241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2021 John Charnley Award: A protocol-based strategy when using hemiarthroplasty or total hip arthroplasty for femoral neck fractures decreases mortality, length of stay, and complications.
    Roberts HJ; Barry J; Nguyen K; Vail T; Kandemir U; Rogers S; Ward D
    Bone Joint J; 2021 Jul; 103-B(7 Supple B):3-8. PubMed ID: 34192920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis.
    Koldkjær Sølling AS; Harsløf T; Langdahl B
    Osteoporos Int; 2019 May; 30(5):995-1002. PubMed ID: 30656367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Yigu® versus Aclasta® in Chinese postmenopausal women with osteoporosis: a multicenter prospective study.
    Li M; Cheng Q; Huo YN; Chao AJ; He L; Xue QY; Xu J; Yan SG; Jin H; Zhang ZL; Lin JH; Jin XL; Xu YJ; Liu F; Xia WB
    Arch Osteoporos; 2022 Jan; 17(1):14. PubMed ID: 35020038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional bone loss following femoral neck fracture: A comparison between cemented and cementless hemiarthroplasty.
    Vidović D; Punda M; Daraboš N; Bekavac-Bešlin M; Bakota B; Matejčić A
    Injury; 2015 Nov; 46 Suppl 6():S52-6. PubMed ID: 26606990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total hip arthroplasty reduces the risk of dislocation after femoral neck fracture.
    Pangaud C; Pioger C; Pauly V; Orleans V; Boyer L; Argenson JN; Ollivier M
    Orthop Traumatol Surg Res; 2023 Jun; 109(4):103575. PubMed ID: 36754167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Bisphosphonates on Osteoporosis Induced by Duchenne Muscular Dystrophy: A Prospective Study.
    Zheng WB; Dai Y; Hu J; Zhao DC; Wang O; Jiang Y; Xia WB; Xing XP; Li M
    Endocr Pract; 2020 Dec; 26(12):1477-1485. PubMed ID: 33471740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.